The three-day program will cover a wide range of pediatric neurological and neurosurgical conditions, from common disorders to complex and rare diseases.
The agreement establishes a framework for broader cooperation between the two institutions as they respond to changing healthcare needs in Qatar.
The hospital will coordinate the collection, while Sidra Medicine will process and store the samples at its specialized Good Manufacturing Practice (GMP) facility, which houses Qatar’s only cord blood bank.
The milestone also makes Qatar the third country worldwide to administer Itvisma and marks a significant step in the country’s precision medicine and rare disease care efforts.
Under the partnership, the two organizations will work together to enhance HMC’s Clinical Trials Unit (CTU), strengthen research expertise, and develop initiatives that support the continued growth of Qatar’s healthcare sector.
The newly launched Medical Observership Program offers structured observational learning opportunities within one of the region’s leading tertiary academic medical centers.
The report highlights how a targeted, mechanism-based approach helped manage a rare and complex form of obesity that developed after severe brain injury in infancy.
The findings come from a mathematical modeling study published in Science Advances, which offers the first population-level estimates of how an HSV-1 vaccine could reshape disease trends.
The ANCC Pathway to Excellence framework evaluates organizations on leadership, safety, professional development, workplace culture, and shared decision-making.
Growing Demand for Pediatric Sports Medicine
The service, led by Dr. Alkhatib, offers comprehensive care that combines advanced surgical techniques with customized rehabilitation programs.